We develop technologies for site-specific drug delivery to the Central Nervous System, in particular the brain, for effective care of high-need patients.
Our Vision
The human brain has 100 billion neurons, each neuron connected to 10 thousand other neurons. Sitting on your shoulders is the most complicated object in the known universe.” Michio Kaku
We overcome barriers by delivering therapies directly to the brain.
Brain Implant Therapeutics (BIT) Pharma was founded in November 2015 by leaders from academia and industry and is based in Graz, Austria.
Technology Innovation
BIT Pharma technology is based on proprietary manufacturing process for tailored drug release at the site of action within the central nervous system (mainly the brain).
cGMP-compliant process
Intellectual Property
Exclusive Manufacture
Years of experience
The BIT Pharma Management Team embraces industry leading experience in non-clinical and clinical development, drug delivery technologies, as well as successful experience in general management.
Funded by seed financing of the BMWFW, processed by Austria Wirtschafts Service.
